Clarius Group LLC Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Clarius Group LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.8% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,089 shares of the medical equipment provider’s stock after purchasing an additional 220 shares during the period. Clarius Group LLC’s holdings in Intuitive Surgical were worth $1,090,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $36,000. Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth $38,000. Finally, DT Investment Partners LLC boosted its holdings in Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after purchasing an additional 36 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. The trade was a 26.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares in the company, valued at $140,595. The trade was a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 48,190 shares of company stock worth $25,012,927. 0.80% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Piper Sandler restated an “overweight” rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Raymond James raised their price target on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Royal Bank of Canada upped their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Finally, Mizuho boosted their price target on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Trading Up 1.5 %

Shares of NASDAQ ISRG opened at $592.64 on Friday. Intuitive Surgical, Inc. has a 12-month low of $362.14 and a 12-month high of $597.68. The company has a market cap of $211.09 billion, a price-to-earnings ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. The stock’s 50 day simple moving average is $540.66 and its 200 day simple moving average is $498.77.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.